1. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Issue 1 (20th May 2021) Authors: Bi, Wenya Linda; Nayak, Lakshmi; Meredith, David M; Driver, Joseph; Du, Ziming; Hoffman, Samantha; Li, Yvonne; Lee, Eudocia Quant; Beroukhim, Rameen; Rinne, Mikael; McFaline-Figueroa, Ricardo; Chukwueke, Ugonma; McCluskey, Christine; Gaffey, Sarah; Cherniack, Andrew D; Stefanik, Jennifer; Doherty... Journal: Neuro-oncology Issue: Volume 24:Issue 1(2022) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CTIM-18. PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723). (14th November 2022) Authors: Iwamoto, Fabio; Tanguturi, Shyam; Desai, Arati; Nayak, Lakshmi; Uhlmann, Erik; Wang, Tony; Lustig, Robert; Hertan, Lauren; Bagley, Stephen; Hayden, Julia; Laforest-Roys, Corey; Muzikansky, Alona; McCluskey, Christine; Chukwueke, Ugonma; McFaline-Figueroa, J Ricardo; Lee, Eudocia; Wen, Patrick Y; ... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS. (9th November 2020) Authors: Reardon, David; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Duda, Gabriel; Muz... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-05. PRELIMINARY RESULTS OF THE NERATINIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (12th November 2021) Authors: Arrillaga-Romany, Isabel; Trippa, Lorenzo; Fell, Geffrey; Lee, Eudocia Quant; Rahman, Rifaquat; Touat, Mehdi; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CTNI-11. CC-115 IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II RANDOMIZED BAYESIAN ADAPTIVE PLATFORM TRIAL. (9th November 2020) Authors: Rahman, Rifaquat; Trippa, Lorenzo; Fell, Geoffrey; Lee, Eudocia; Arrillaga-Romany, Isabel; Touat, Mehdi; McCluskey, Christine; Brunno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, Louis; Hepel, Jaroslaw; Elinzano, Heinrich... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-12. PRELIMINARY RESULTS OF THE ABEMACICLIB ARM IN THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT): A PHASE II PLATFORM TRIAL USING BAYESIAN ADAPTIVE RANDOMIZATION. (9th November 2020) Authors: Wen, Patrick; Trippa, Lorenzo; Lee, Eudocia; Fell, Geoffrey; Rahman, Rifaquat; Arrillaga-Romany, Isabel; Touat, Mehdi; McCluskey, Christine; Brunno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, Louis; Hepel, Jaroslaw; Elin... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE. (12th November 2021) Authors: Rahman, Rifaquat; Trippa, Lorenzo; Lee, Eudocia Quant; Arrillaga-Romany, Isabel; Touat, Mehdi; Fell, Geffrey; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (9th November 2020) Authors: Nayak, Lakshmi; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Gaffey, Sarah; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Dud... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma. Issue 6 (7th January 2015) Authors: Lee, Eudocia Q.; Reardon, David A.; Schiff, David; Drappatz, Jan; Muzikansky, Alona; Grimm, Sean A.; Norden, Andrew D.; Nayak, Lakshmi; Beroukhim, Rameen; Rinne, Mikael L.; Chi, Andrew S.; Batchelor, Tracy T.; Hempfling, Kelly; McCluskey, Christine; Smith, Katrina H.; Gaffey, Sarah C.; Wrigley, B... Journal: Neuro-oncology Issue: Volume 17:Issue 6(2015:Jun.) Page Start: 862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗